Compounds > 4-dimethylaminophenylacetate
Page last updated: 2024-12-08

4-dimethylaminophenylacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-N,N-dimethylaminophenylacetic acid: accelerator for dental composite polymerization [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID152203
SCHEMBL ID202439
MeSH IDM0097045

Synonyms (32)

Synonym
2-[4-(dimethylamino)phenyl]acetic acid
dmapaa
inchi=1/c10h13no2/c1-11(2)9-5-3-8(4-6-9)7-10(12)13/h3-6h,7h2,1-2h3,(h,12,13
4-(dimethylamino)phenylacetic acid, 97%
A811237
4-(dimethylamino)phenylacetic acid
17078-28-3
4-n,n-dimethylaminophenylacetic acid
4-dimethylaminophenylacetate
benzeneacetic acid, 4-(dimethylamino)-
AKOS009158418
2-(4-(dimethylamino)phenyl)acetic acid
[4-(dimethylamino)phenyl]acetic acid
4-(dimethylamino)benzeneacetic acid
FT-0637491
AM20030139
KQGHTOZUPICELS-UHFFFAOYSA-N
4-(dimethylamino)phenyl acetic acid
4-(n,n-dimethylamino)phenylacetic acid
(4-dimethylaminophenyl)acetic acid
(4-dimethylamino-phenyl)-acetic acid
SCHEMBL202439
TS-02500
DTXSID90168941
mfcd00075591
J-010650
4-dimethylaminophenylacetic acid
2-(4-(dimethylamino)phenyl)acetic acid;4-n,n-dimethylaminophenylacetic acid
BCP22029
EN300-41190
CS-0145762
SY239728
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.09 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
clorgyline
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.. clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.		1.9810aromatic ether;
dichlorobenzene;
terminal acetylenic compound;
tertiary amino compound		antidepressant;
EC 1.4.3.4 (monoamine oxidase) inhibitor
phenylethyl alcohol
Phenylethyl Alcohol: An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery.. 2-phenylethanol : A primary alcohol that is ethanol substituted by a phenyl group at position 2.		1.9610benzenes;
primary alcohol		Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
acrylamide
[no description available]		1.9910acrylamides;
N-acylammonia;
primary carboxamide		alkylating agent;
carcinogenic agent;
Maillard reaction product;
mutagen;
neurotoxin
acrylic acid
acrylic acid: RN given refers to parent cpd. acrylic acid : A alpha,beta-unsaturated monocarboxylic acid that is ethene substituted by a carboxy group.		1.9910alpha,beta-unsaturated monocarboxylic acidmetabolite
n,n'-methylenebisacrylamide
[no description available]		1.9910
selegiline
Selegiline: A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl.		1.9810selegiline;
terminal acetylenic compound		geroprotector
benzeneboronic acid
[no description available]		1.9910boronic acids
ConditionIndicatedRelationship StrengthStudiesTrials